The global market for medical robotics is expanding as hospitals face staff shortages, rising costs, and demand for less invasive care. Surgical platforms, automated pharmacy systems, and rehabilitation exoskeletons are moving from research into routine workflows, supported by better imaging and connectivity.
Grand View Report has tracked this trajectory across multiple industry verticals and found that healthcare leads in adoption once funding models align with patient outcomes. Forecasts point to double-digit compound growth well into the next decade, driven by aging populations, clinician burnout, and falling automation costs.
In Australia, the new Royal Adelaide Hospital runs automated guided vehicles for meals and linen, while researchers in Melbourne's Parkville precinct are piloting rehabilitation robots for stroke survivors. With vast distances between regional towns and metro hospitals, telepresence is being workshopped by state health authorities from Perth to Brisbane.
Surgical platforms remain the market flagship, led by systems such as the da Vinci and a growing wave of Asian and European competitors. In Australia, uptake is concentrated in private hospital groups on the east coast, where shorter patient stays justify the capital outlay.
Public hospitals have moved more slowly, partly because the Therapeutic Goods Administration classifies these as high-risk and partly because procurement cycles stretch across budget years. Newer modular platforms are entering at lower price points, and subscription-based procurement is starting to appear.
Rehabilitation robotics is the segment most shaped by Australian policy. The National Disability Insurance Scheme funds many assistive devices, including exoskeletons and gait trainers, opening a route to market that few other countries offer.
Aged care providers across Sydney, Melbourne, and the Gold Coast are trialling robotic companions and mobility aids. Stroke rehabilitation is the standout use case, with robotic systems delivering the high-repetition therapy that human therapists alone cannot match.
Behind the scenes, the most visible deployment in many Australian hospitals is in pharmacy and logistics. Automated dispensing cabinets and robotic pick-and-pack systems reduce medication errors and free pharmacists for clinical work.
Many of these projects are bundled with infrastructure upgrades, with parallels to the regional construction opportunities analysed in other markets where ceiling tracks, lifts, and clean rooms must be retrofitted. The challenge for Australian procurement teams is the heterogeneity of public hospital campuses, many on heritage sites.
The next wave of value is software. Computer vision recognises tissue planes in real time, while machine learning models suggest instrument trajectories. Operating rooms from Westmead to Fiona Stanley Hospital are pulling imaging, pathology, and live vitals into a single console.
For vendors planning to enter or expand, broader regional expansion insights from cross-border consultancies can help navigate licensing and data residency. Australian buyers favour vendors with local support and clear TGA conformity pathways.
Money shapes adoption more than any other factor. In Australia, Medicare rebates, private health insurance schedules, and state capital budgets create a layered funding environment that suppliers must understand.
Procurement is typically handled at the state level, so a successful pilot in one jurisdiction does not automatically translate to another. Vendors should study startup market entry strategies in other regulated sectors, since the playbook around certification and evidence is broadly similar. Reimbursement remains the slowest piece, and until item numbers align, the case will rest on throughput and length-of-stay gains.
Forecasts across robotics in healthcare show consistently strong growth, but the picture varies sharply by region and application.
| Segment | Leading Region | Australia Position | Forecast 2025-2030 CAGR |
|---|---|---|---|
| Surgical robotics | North America | Mid-tier, public-private split | 11-14% |
| Rehabilitation & exoskeletons | Asia-Pacific | Strong, NDIS-supported | 13-16% |
| Pharmacy & logistics automation | Europe | Catching up, retrofit-heavy | 9-12% |
| Service & social robots | Japan, South Korea | Early pilot stage | 15-18% |
| Diagnostics & lab automation | North America | Steady, pathology-led | 10-13% |
Asia-Pacific is expected to overtake North America in unit volume by the early 2030s, though North America keeps the highest revenue per installation. Australia's strongest position is in rehabilitation, where policy and demographics align, and weakest in service robotics, where acceptance still lags.
Robots do not replace clinicians; they re-skill them. Surgical teams need dry-lab time, physiotherapists need training, and biomedical engineers are in short supply to maintain complex fleets. The Royal Flying Doctor Service is also discussing how telepresence robotics could support clinicians in remote clinics across the Top End.
Australian workplace culture values teamwork and a fair go, so adoption is smoother when systems are framed as supporting clinical judgement rather than replacing it, with senior surgeons paired with registrars on console.
Organisations planning a robotics investment should focus on these points:
The core takeaway is that successful robotics adoption rests as much on funding pathways, training, and procurement design as on the technology. Hospitals pairing investment with workflow redesign and a realistic funding plan will be best placed to capture value through the rest of the decade.
Oct, 2020 | Pages: 160 | Read More
Oct, 2020 | Pages: 150 | Read More
Oct, 2020 | Pages: 164 | Read More
Oct, 2020 | Pages: 172 | Read More
Oct, 2020 | Pages: 160 | Read More
Oct, 2020 | Pages: 160 | Read More
We gather and analyze industry information to generate reports
With our solutions, you can discover the opportunities
To have a company representative contact you directly, please complete the form below.